These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 28369424

  • 1. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A, Scorzolini L, Cipolla A, Mascellino MT, Cancelli F, Castaldi D, D'Abramo A, D'Agostino C, Russo G, Ciardi MR, Mastroianni CM, Vullo V.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):1981-1984. PubMed ID: 28369424
    [Abstract] [Full Text] [Related]

  • 2. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH, Chen CC, Lee MF, Chuang YC, Tang HJ, Yu WL.
    J Microbiol Immunol Infect; 2017 Dec 01; 50(6):931-939. PubMed ID: 28716360
    [Abstract] [Full Text] [Related]

  • 3. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M, Vourli S, Georgiou PC, Pournaras S, Daikos GRL, Mouton JW, Meletiadis J.
    J Antimicrob Chemother; 2019 Feb 01; 74(2):387-394. PubMed ID: 30376071
    [Abstract] [Full Text] [Related]

  • 4. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, Tsakris A.
    Int J Antimicrob Agents; 2011 Mar 01; 37(3):244-7. PubMed ID: 21236643
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I, Pena I, Picazo JJ, Rodríguez-Avial C, Culebras E.
    Int J Antimicrob Agents; 2015 Dec 01; 46(6):616-21. PubMed ID: 26391381
    [Abstract] [Full Text] [Related]

  • 6. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
    Oliva A, Gizzi F, Mascellino MT, Cipolla A, D'Abramo A, D'Agostino C, Trinchieri V, Russo G, Tierno F, Iannetta M, Mastroianni CM, Vullo V.
    Clin Microbiol Infect; 2016 Feb 01; 22(2):147-153. PubMed ID: 26409059
    [Abstract] [Full Text] [Related]

  • 7. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
    Poirel L, Kieffer N, Nordmann P.
    J Antimicrob Chemother; 2016 Jan 01; 71(1):156-61. PubMed ID: 26416781
    [Abstract] [Full Text] [Related]

  • 8. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan 01; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 9. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L, Fazeli H, Moghim S, Nasr Isfahani B.
    Cell Mol Biol (Noisy-le-grand); 2018 Jan 31; 64(1):70-74. PubMed ID: 29412797
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC, Dinh A, Nordmann P, Mouton W, Tattevin P, Ghout I, Jayol A, Aimer O, Gatin L, Verdier MC, Saleh-Mghir A, Laurent F.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2666-2675. PubMed ID: 31263884
    [Abstract] [Full Text] [Related]

  • 11. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH, Clancy CJ, Cheng S, Shields RK, Chen L, Doi Y, Zhao Y, Perlin DS, Kreiswirth BN, Nguyen MH.
    Antimicrob Agents Chemother; 2013 May 01; 57(5):2147-53. PubMed ID: 23459476
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F, Abulaila A, Aktas Z, Oncul O.
    Antimicrob Resist Infect Control; 2020 May 19; 9(1):70. PubMed ID: 32430058
    [Abstract] [Full Text] [Related]

  • 13. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
    Cojutti P, Sartor A, Bassetti M, Scarparo C, Pea F.
    J Glob Antimicrob Resist; 2018 Sep 19; 14():238-241. PubMed ID: 29775786
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Tängdén T, Hickman RA, Forsberg P, Lagerbäck P, Giske CG, Cars O.
    Antimicrob Agents Chemother; 2014 Sep 19; 58(3):1757-62. PubMed ID: 24395223
    [Abstract] [Full Text] [Related]

  • 15. Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains.
    Tapalski DV, Timoshkova EV, Petrovskaya TA, Osipkina OV, Karpov IA.
    Klin Lab Diagn; 2021 May 23; 66(5):304-309. PubMed ID: 34047517
    [Abstract] [Full Text] [Related]

  • 16. Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates.
    Stein C, Makarewicz O, Bohnert JA, Pfeifer Y, Kesselmeier M, Hagel S, Pletz MW.
    PLoS One; 2015 May 23; 10(6):e0126479. PubMed ID: 26067824
    [Abstract] [Full Text] [Related]

  • 17. Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
    Michail G, Labrou M, Pitiriga V, Manousaka S, Sakellaridis N, Tsakris A, Pournaras S.
    Antimicrob Agents Chemother; 2013 Dec 23; 57(12):6028-33. PubMed ID: 24060874
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E, Azap OK, Çolakoğlu Ş, Arslan H.
    Diagn Microbiol Infect Dis; 2013 Jul 23; 76(3):335-8. PubMed ID: 23726147
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S.
    J Antimicrob Chemother; 2014 Jul 23; 69(7):1856-65. PubMed ID: 24648503
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
    Papoutsaki V, Galani I, Papadimitriou E, Karantani I, Karaiskos I, Giamarellou H.
    J Glob Antimicrob Resist; 2020 Mar 23; 20():98-104. PubMed ID: 31398495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.